# Egypt Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Egypt HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Egypt (EGY)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $129.9M
- Products: 28
- Buyer markets: 29
- Average CAGR: +14.7%
- Global sector size: $531.8B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $306.3B | $17.4M | $115.4B | +11.2% | 21 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $30.8B | $22.2M | $22.1B | +16.5% | 13 | +0.1% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $51.8B | $3.5M | $21.0B | +55.9% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $21.0K | $10.7B | -0.4% | 3 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $18.4B | $46.0M | $10.4B | +38.0% | 4 | +0.7% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $12.4B | $3.1M | $9.6B | +4.1% | 4 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $14.3B | $2.8K | $9.5B | -7.9% | 4 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $8.3B | $44.7 | $9.1B | -31.3% | 2 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $69.1K | $8.0B | +9.6% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | $49.9K | $7.4B | -23.1% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $17.0B | $10.6K | $7.3B | -2.4% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $24.4K | $4.1B | -8.1% | 2 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $4.9K | $2.2B | -10.7% | 2 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $3.1B | $4.3K | $2.1B | +86.8% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $2.6M | $1.9B | +60.2% | 1 | +0.2% |
| HS 310540 - Fertilizers, mineral or chemical: ammonium dihydrogenorthophosphate (monoammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $4.7M | $1.8B | +76.5% | 1 | +0.2% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.1B | $8.4K | $1.4B | -68.3% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $28.4 | $1.4B | +58.7% | 1 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.6B | $5.1K | $1.4B | +5.7% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $990.8K | $1.4B | +230.2% | 1 | +0.1% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $8.2K | $1.4B | +33.2% | 1 | +0.0% |
| HS 310530 - Fertilizers, mineral or chemical: diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $18.2M | $1.3B | -7.4% | 1 | +0.7% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $613.1 | $1.1B | -1.7% | 1 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $2.3B | $0.0 | $1.1B | +28.8% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $3.5K | $1.0B | -4.8% | 1 | +0.0% |
| HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $7.3M | $1.0B | +11.0% | 1 | +0.4% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $67.0K | $989.9M | +3.2% | 1 | +0.0% |
| HS 310559 - Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | $1.2B | $3.7M | $939.1M | +27.8% | 1 | +1.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $43.5B calculated opportunity across 11 products.
- Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products.
- Belgium (BEL): $25.0B calculated opportunity across 6 products.
- Germany (DEU): $23.8B calculated opportunity across 8 products.
- China (CHN): $15.4B calculated opportunity across 5 products.
- Netherlands (NLD): $14.7B calculated opportunity across 4 products.
- France (FRA): $12.4B calculated opportunity across 7 products.
- Spain (ESP): $11.5B calculated opportunity across 6 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- United Kingdom (GBR): $9.2B calculated opportunity across 4 products.
- Canada (CAN): $7.5B calculated opportunity across 4 products.
- Mexico (MEX): $5.7B calculated opportunity across 2 products.

## Growth stars

- HS 291736: +230.2% average CAGR, $1.4B calculated opportunity.
- HS 381512: +86.8% average CAGR, $2.1B calculated opportunity.
- HS 310540: +76.5% average CAGR, $1.8B calculated opportunity.
- HS 382319: +60.2% average CAGR, $1.9B calculated opportunity.
- HS 300670: +58.7% average CAGR, $1.4B calculated opportunity.
- HS 300215: +55.9% average CAGR, $21.0B calculated opportunity.
- HS 300212: +38.0% average CAGR, $10.4B calculated opportunity.
- HS 340220: +33.2% average CAGR, $1.4B calculated opportunity.
- HS 300214: +28.8% average CAGR, $1.1B calculated opportunity.
- HS 310559: +27.8% average CAGR, $939.1M calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $115.4B calculated opportunity.
- HS 382499: 13 buyer markets, $22.1B calculated opportunity.
- HS 300215: 6 buyer markets, $21.0B calculated opportunity.
- HS 300212: 4 buyer markets, $10.4B calculated opportunity.
- HS 382600: 4 buyer markets, $9.6B calculated opportunity.
- HS 293499: 4 buyer markets, $9.5B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 300439: 4 buyer markets, $7.4B calculated opportunity.
- HS 382200: 4 buyer markets, $7.3B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.